Fidia S.p.A. (BIT:FDA)
0.1202
-0.0018 (-1.48%)
At close: Jan 9, 2026
Fidia Employees
Fidia had 159 employees as of December 31, 2024. The number of employees decreased by 34 or -17.62% compared to the previous year.
Employees
159
Change (1Y)
-34
Growth (1Y)
-17.62%
Revenue / Employee
€150,929
Profits / Employee
€15,657
Market Cap
1.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | -20 | -9.22% |
| Dec 31, 2021 | 217 | -54 | -19.93% |
| Dec 31, 2020 | 271 | -42 | -13.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Poste Italiane | 125,097 |
| Leonardo S.p.a. | 60,468 |
| Webuild | 43,573 |
| Iveco Group | 36,046 |
| Prysmian | 31,857 |
| Fincantieri | 22,586 |
| Danieli & C. Officine Meccaniche | 10,009 |
| Ariston Holding | 9,947 |
Fidia News
- 2 days ago - uniQure Stock Jumps After Scheduling FDA Type A Meeting For AMT‑130 Approval Pathway - Benzinga
- 2 days ago - Mesoblast Stock Rises On Strong Year‑Over‑Year Growth In Ryoncil Sales - Benzinga
- 2 days ago - Camurus's NDA Resubmission For Oclaiz Gets Accepted By FDA - Nasdaq
- 2 days ago - Aquestive Stock Slides After FDA Flags Issues With Allergy Drug Application - Benzinga
- 2 days ago - CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday - Benzinga
- 2 days ago - Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline Advances - Benzinga
- 2 days ago - AQST Faces FDA Setback Regarding Anaphylm NDA - GuruFocus
- 2 days ago - Here's Why Biotech ETFs Are Rallying Hard - Nasdaq